aluminum phosphate has been researched along with Lassitude in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Villiers, PJ; Emini, EA; Gruber, WC; Jansen, KU; Jayawardene, D; Juergens, C; Moodley, K; Schmoele-Thoma, B; Scott, DA | 1 |
1 trial(s) available for aluminum phosphate and Lassitude
Article | Year |
---|---|
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-labe
Topics: Aged; Aged, 80 and over; Aluminum Compounds; Chemistry, Pharmaceutical; Double-Blind Method; Fatigue; Female; Humans; Immunogenetic Phenomena; Male; Pain; Phosphates; Pneumococcal Infections; Pneumococcal Vaccines; South Africa; Vaccines, Conjugate | 2014 |